Literature DB >> 27582872

Mediastinal dysgerminoma complicating pregnancy.

K Manikandan1, P Veena1, S Elamurugan1, S Soundararaghavan1.   

Abstract

Malignancy complicating pregnancy represents one of the most challenging clinical situations. Lack of evidence and the presence of the dependent fetus contribute to the management dilemma. A 26-year-old primigravida presented at 23 weeks of gestation with a bulging substernal mass. Fine-needle aspiration was reported as mediastinal dysgerminoma. She was treated with weekly bleomycin and three weekly cisplatin and etoposide (BEP). Maternal neutropenia after 11 weeks of bleomycin required colony stimulator factor. Fetal growth restriction necessitated delivery at 31 weeks. Significant clinical and radiological tumour regression was noted after chemotherapy. Postnatally mother received external beam radiotherapy but the disease worsened two weeks after the completion of radiotherapy. Mediastinal dysgerminoma differs from the ovarian counterpart and therefore therapeutic success reports on ovarian germ cell tumours complicating pregnancy cannot be extrapolated. The safety of the BEP regimen for the fetus is yet to be established.

Entities:  

Keywords:  cancer; high-risk pregnancy; maternal–fetal medicine; mediastinal dysgerminoma; oncology

Year:  2012        PMID: 27582872      PMCID: PMC4989700          DOI: 10.1258/om.2011.110066

Source DB:  PubMed          Journal:  Obstet Med        ISSN: 1753-495X


  18 in total

Review 1.  Ruptured ovarian endodermal sinus tumor diagnosed during pregnancy: case report and review of the literature.

Authors:  Mongkol Benjapibal; Pattama Chaopotong; Chairatana Leelaphatanadit; Atthapon Jaishuen
Journal:  J Obstet Gynaecol Res       Date:  2010-10       Impact factor: 1.730

2.  Yolk sac tumor of the ovary during pregnancy: a case report.

Authors:  Yoichi Aoki; Masahiko Higashino; Shiro Ishii; Kenichi Tanaka
Journal:  Gynecol Oncol       Date:  2005-07-26       Impact factor: 5.482

3.  Primary germ cell tumors of the mediastinum: III. Yolk sac tumor, embryonal carcinoma, choriocarcinoma, and combined nonteratomatous germ cell tumors of the mediastinum--a clinicopathologic and immunohistochemical study of 64 cases.

Authors:  C A Moran; S Suster; M N Koss
Journal:  Cancer       Date:  1997-08-15       Impact factor: 6.860

4.  Pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for malignant ovarian germ cell tumors: report of 2 cases.

Authors:  Jung-Yeol Han; Alejandro A Nava-Ocampo; Tae-Jin Kim; Jae-Uk Shim; Chong-Taik Park
Journal:  Reprod Toxicol       Date:  2005 Mar-Apr       Impact factor: 3.143

5.  A case of ovarian endodermal sinus tumor diagnosed during pregnancy.

Authors:  Isarin Thanaboonyawat; Mongkol Benjapibal
Journal:  J Med Assoc Thai       Date:  2008-05

6.  A 25-year single institution experience with surgery for primary mediastinal nonseminomatous germ cell tumors.

Authors:  Kenneth A Kesler; Karen M Rieger; Zane T Hammoud; Laura E Kruter; Susan M Perkins; Mark W Turrentine; Bryan P Schneider; Lawrence H Einhorn; John W Brown
Journal:  Ann Thorac Surg       Date:  2008-02       Impact factor: 4.330

7.  Ovarian malignant immature teratoma associated with pregnancy--a case report.

Authors:  O Poujade; E Pujade-Lauraine; M Levardon; D Luton
Journal:  Eur J Gynaecol Oncol       Date:  2008       Impact factor: 0.196

8.  A favorable maternal and neonatal outcome following chemotherapy with etoposide, bleomycin, and cisplatin for management of grade 3 immature teratoma of the ovary.

Authors:  Fatemeh Ghaemmaghami; Fatemeh Abbasi; Akram Ghahghai Nezam Abadi
Journal:  J Gynecol Oncol       Date:  2009-12-28       Impact factor: 4.401

9.  Endodermal sinus tumor diagnosed in pregnancy: a case report.

Authors:  H Robova; L Rob; M Hrehorcak; P Zoban; R Prusa
Journal:  Int J Gynecol Cancer       Date:  2007 Jul-Aug       Impact factor: 3.437

10.  Ovarian and extragonadal malignant germ-cell tumors in females: a single-institution experience with 43 patients.

Authors:  J I Mayordomo; L Paz-Ares; F Rivera; M López-Brea; E López Martín; C Mendiola; M T Díaz-Puente; P Lianes; M D García-Prats; H Cortés-Funes
Journal:  Ann Oncol       Date:  1994-03       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.